Vineeta Agarwala leads a16z Bio + Health investments in biotechnology, life sciences software and digital health, emphasizing technology and data that improve medicines and care.
Independent Board Director
Board Chair and Board Member
Serves as Board Chair after joining the NVCA board in 2021.
Committee Member, Committee to Visit HMS and HSDM
Serves on the committee that visits Harvard Medical School and the Harvard School of Dental Medicine.
General Partner, Bio + Health
Invests in biotech, digital health, life-sciences tools, and diagnostics.
Adjunct Clinical Assistant Professor
Provides clinical care in primary care and population health, including cancer-survivorship consultations.
Venture Partner, Life Sciences
Invested in data-driven biotechnology companies on GV's life-sciences team.
Director of Product Management
Led the Foundation Medicine partnership connecting treatment records and tumor-sequencing data for oncology research.
MD/PhD Researcher
Studied the genetic causes of common human diseases, including population genetics, next-generation sequencing, and clinical translation.
Data Scientist
Worked on data products for patient access and referral management.
Business Analyst
Consulted for biotechnology, pharmaceutical and medical-device companies.
BS, Biophysics
PhD in Biophysics (2013); MD (2015)
